Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
Tissue Antigens|February 1, 1988
Heterogeneity in the mitogenic response of peripheral blood mononuclear cells to a pan T monoclonal antibodyP Carandente Giarrusso, M C Turco, L Corbo, et al.European Journal of Immunology|May 16, 1998
Immunogenicity of the ALLAVGATK (gp100[17-25]) peptide in HLA-A3.1 melanoma patientsC Castelli, A Mazzocchi, F Rini, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 1998
Metabolism of delavirdine, a human immunodeficiency virus type-1 reverse transcriptase inhibitor, by microsomal cytochrome P450 in humans, rats, and other species: probable involvement of CYP2D6 and CYP3AR L Voorman, S M Maio, M J Hauer, et al.International Journal of Cancer|March 17, 2001
Unbalanced expression of HLA-A and -B antigens: a specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-gammaA Gasparollo, S Coral, M Ciullo, et al.La Clinica Terapeutica|August 25, 2000
Emerging role of protectin (CD59) in humoral immunotherapy of solid malignanciesE Fonsatti, M Altomonte, S Coral, et al.Cancer Research|June 1, 1989
Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potentialM Maio, B Gulwani, J A Langer, et al.Cancer Immunology, Immunotherapy : CII|July 22, 1999
In vitro analysis of the melanoma/endothelium interaction increasing the release of soluble intercellular adhesion molecule 1 by endothelial cellsE Fonsatti, E Lamaj, S Coral, et al.International Journal of Oncology|July 17, 1998
Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies (Review)M Maio, L I Brasoveanu, S Coral, et al.Journal of Cellular Physiology|May 31, 2001
Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignanciesE Fonsatti, L Del Vecchio, M Altomonte, et al.Molecular Immunology|March 1, 1993
Insertion of constant region domains of human IgG1 into CD4-PE40 increases its plasma half-lifeJ K Batra, S Kasturi, M G Gallo, et al.Pageof 9